Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study

Hessel Peters-Sengers1,2, Joe M Butler3,4, Fabrice Uhel3,4

  • 1Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Room T1.240, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. h.peterssengers@amsterdamumc.nl.

Intensive Care Medicine
|December 13, 2021
PubMed
Abstract

Insights

Sepsis source significantly impacts host response, with abdominal sepsis showing heightened inflammation and coagulation. Understanding these source-specific differences is crucial for targeted sepsis treatments and clinical trials.

Area of Science:

  • Critical Care Medicine
  • Immunology
  • Genomics

Background:

  • Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
  • The impact of infection source on host response in sepsis remains incompletely understood.
  • Identifying source-specific host responses can refine diagnostic and therapeutic strategies.

Purpose of the Study:

  • To compare host responses in sepsis patients based on the identified source of infection.
  • To investigate differences in plasma biomarkers and leukocyte transcriptomes across various sepsis origins.
  • To determine if infection source independently influences sepsis patient outcomes.

Main Methods:

  • Analysis of 16 plasma host response biomarkers in 621 sepsis patients from the MARS cohort.
  • Comparison of blood leukocyte transcriptomes in a subgroup of 335 patients stratified by infection source.
  • Evaluation of clinical profiles and 30-day survival in 2019 sepsis patients.

Main Results:

  • Abdominal sepsis exhibited stronger inflammatory, cytokine, and coagulation responses compared to respiratory sepsis.
  • Urinary, cardiovascular, and skin infections showed prominent endothelial cell activation.
  • Central nervous system infections presented with minimal host response aberrations.
  • Leukocyte transcriptional analysis revealed significant differences in immune and metabolic pathways between infection sources.
  • Infection source was an independent predictor of 30-day mortality in sepsis patients.

Conclusions:

  • Sepsis exhibits heterogeneity driven by source-specific host response dysregulations.
  • Tailoring patient selection for immune modulatory drug trials based on infection source is recommended.
  • Further research into source-specific sepsis pathophysiology is warranted.